Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Boehringer Ingelheim
Johnson and Johnson
Harvard Business School
Merck

Last Updated: February 21, 2020

DrugPatentWatch Database Preview

Actavis Totowa Company Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACTAVIS TOTOWA, and what generic and branded alternatives to ACTAVIS TOTOWA drugs are available?

ACTAVIS TOTOWA has twenty-two approved drugs.



Summary for Actavis Totowa
US Patents:0
Tradenames:17
Ingredients:17
NDAs:22
Patent Litigation for Actavis Totowa: See patent lawsuits for Actavis Totowa

Drugs and US Patents for Actavis Totowa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Totowa TOPIRAMATE topiramate TABLET;ORAL 078637-004 Feb 27, 2013 DISCN No No   Start Trial   Start Trial
Actavis Totowa TOPIRAMATE topiramate TABLET;ORAL 078637-002 Feb 27, 2013 DISCN No No   Start Trial   Start Trial
Actavis Totowa OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 078803-001 Aug 8, 2012 AP RX No Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Merck
Harvard Business School
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.